Assessing the Prognostic Performance of Pan Immune-Inflammation Value and Inflammatory Biomarkers in Critically Ill Patients with Community-Acquired Pneumonia
- 10 February 2026
- journal article
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Abstract
Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality, particularly among critically ill patients in intensive care units (ICUs). Although various clinical scoring systems are used for prognostic stratification, their limitations have prompted interest in novel biomarkers. The pan-immune-inflammation value (PIIV) is a recently proposed index assessing systemic inflammation and immune status. This study investigates the relationship between PIIV, traditional inflammatory markers, and mortality outcomes in ICU-admitted CAP patients. A total of 248 CAP patients were retrospectively analyzed. Demographic, clinical, and laboratory data were obtained from electronic medical records. Associations between these variables and 30-day mortality were evaluated. Univariate and multivariate logistic regression analyses identified independent mortality predictors, and Receiver Operating Characteristic (ROC) analysis assessed diagnostic performance. Among 248 patients, 156 (62.9%) died. PIIV, procalcitonin, lactate, and neutrophil-lymphocyte ratio (NLR) levels were significantly higher in non-survivors. Multivariable analysis identified PIIV (adjusted OR: 1.227; 95% CI: 1.097–1.372; p < 0.001), lactate (adjusted OR: 1.637; 95% CI: 1.290–2.077; p < 0.001), and procalcitonin (adjusted OR: 1.017; 95% CI: 1.002–1.033; p = 0.022), as independent predictors of 30-day mortality. ROC analysis showed optimal cut-off values: PIIV ≥1928.3 (54.5% sensitivity, 70.7% specificity), lactate ≥1.6 mmol/L (75.6% sensitivity), and procalcitonin ≥1.26 ng/mL (73.7% sensitivity, 61.9% specificity). PIIV is an independent prognostic indicator of mortality in CAP patients, reflecting systemic inflammation through multiple hematological parameters. It may capture complex immune-inflammatory dynamics and serve as a useful adjunctive biomarker alongside established markers.Keywords
This publication has 28 references indexed in Scilit:
- Decoding community-acquired pneumonia: a systematic review and analysis of diagnostic criteria and definitions used in clinical trialsClinical Microbiology and Infection, 2024
- The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumoniaClinical Medicine, 2024
- Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP)Scientific Reports, 2024
- Prognostic value of pan immune-inflammation value in patients undergoing unprotected left main coronary artery stentingBiomarkers in Medicine, 2024
- How to assess survival prognosis in patients hospitalized for community-acquired pneumonia in 2024?Current Opinion in Critical Care, 2024
- Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trialClinical Microbiology and Infection, 2024
- Updating cut-off values of severity scoring systems for community-acquired pneumonia to orchestrate more predictive accuracyAnnals of Medicine, 2023
- The ratio of neutrophil-to-lymphocyte and platelet-to-lymphocyte and association with mortality in community-acquired pneumonia: a derivation-validation cohort studyInfection, 2023
- Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severityClinics and Research in Hepatology and Gastroenterology, 2012
- Mean platelet volume as an indicator of disease severity in patients with acute pancreatitisClinics and Research in Hepatology and Gastroenterology, 2012